Abstract
Background
Parathyroid carcinoma is a rare disease. Conflicting results on prognostic factors and extent of surgical resection for patients with parathyroid carcinoma have been made based on small sample sizes. A large, robust dataset is needed to help address some of the controversies.
Methods
A retrospective review of patients with parathyroid carcinoma in the National Cancer Data Base from 1985 to 2006 was performed. Characteristics of the cohort and type of treatment were evaluated. Prognostic factors were assessed with Cox proportional hazards regression models and 5- and 10-year OS rates were determined.
Results
There were 733 evaluable patients with a mean age of 56.1 ± 15.3 years (median 57, range 15–89) and mean tumor size of 29.6 ± 18.4 mm (median 25.0 mm, range 10.0–150.0). Tumor size, age at diagnosis, male sex, positive nodal status, and complete tumor resection had hazard ratios for death of 1.02 (1.01–1.02, p < 0.0001), 1.06 (1.05–1.07, p < 0.0001), 1.67 (1.24–2.25, p = 0.0008), 1.25 (0.57–2.76, p = 0.6), and 0.42 (0.22–0.81, p = 0.01), respectively, on multivariable analysis. Patients who had removal of the parathyroid tumor with concomitant resection of adjacent organs had HR for death of 0.70 (0.35–1.41, p = 0.3). The 5- and 10-year OS rates were 82.3 and 66 % respectively.
Conclusions
Patient age, tumor size, and sex have modest effects on survival in patients with parathyroid carcinoma. A staging system with prognostic value for parathyroid carcinoma should include at least these pertinent prognostic factors.
Similar content being viewed by others
References
Busaidy NL, Jimenez C, Habra MA, et al. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004;26:716–26.
Lee PK, Jarosek SL, Virnig BA, et al. Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer. 2007;109:1736–41.
Al-Kurd A, Mekel M, Mazeh H. Parathyroid carcinoma. Surg Oncol. 2014;23:107–14.
Kebebew E. Parathyroid carcinoma. Curr Treat Options Oncol. 2001;2:347–54.
Harari A, Waring A, Fernandez-Ranvier G, et al. Parathyroid carcinoma: a 43-year outcome and survival analysis. J Clin Endocrinol Metab. 2011;96:3679–86.
Wei CH, Harari A. Parathyroid carcinoma: update and guidelines for management. Curr Treat Options Oncol. 2012;13:11–23.
Hundahl SA, Fleming ID, Fremgen AM, et al. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1999;86:538–44.
Sandelin K, Auer G, Bondeson L, et al. Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg. 1992;16:724–31.
Shaha AR, Shah JP. Parathyroid carcinoma: a diagnostic and therapeutic challenge. Cancer. 1999;86:378–80.
Talat N, Schulte KM. Clinical presentation, staging and long-term evolution of parathyroid cancer. Ann Surg Oncol. 2010;17:2156–74.
Schulte KM, Gill AJ, Barczynski M, et al. Classification of parathyroid cancer. Ann Surg Oncol. 2012;19:2620–8.
Hsu KT, Sippel RS, Chen H, et al. Is central lymph node dissection necessary for parathyroid carcinoma? Surgery. 2014;156:1336–41; discussion 1341.
Acknowledgments
Elliot A. Asare, MD, is supported by the American College of Surgeons Clinical Scholars in Residence Program.
Disclosures
All authors have no financial disclosures.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Asare, E.A., Sturgeon, C., Winchester, D.J. et al. Parathyroid Carcinoma: An Update on Treatment Outcomes and Prognostic Factors from the National Cancer Data Base (NCDB). Ann Surg Oncol 22, 3990–3995 (2015). https://doi.org/10.1245/s10434-015-4672-3
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-015-4672-3